ACB
Aurora CannabisACB
ACB
About: Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Employees: 1,130
0
Funds holding %
of 6,812 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
67% more call options, than puts
Call options by funds: $47.2M | Put options by funds: $28.3M
15% more capital invested
Capital invested by funds: $18.4M [Q2] → $21.2M (+$2.79M) [Q3]
0.71% less ownership
Funds ownership: 7.29% [Q2] → 6.58% (-0.71%) [Q3]
12% less funds holding
Funds holding: 162 [Q2] → 142 (-20) [Q3]
18% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 34
59% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 34
Research analyst outlook
We haven’t received any recent analyst ratings for ACB.
Financial journalist opinion
Based on 4 articles about ACB published over the past 30 days
Negative
Market Watch
5 hours ago
Cannabis sector limps into 2025 because ‘the gold rush is over'
Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in equity prices tied to the business of legalized marijuana in the U.S.
Positive
MarijuanaStocks
1 day ago
2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by 2025, legalization efforts are gaining traction. Recent news highlights growing bipartisan support for federal cannabis reform in the U.S., which could further boost industry expansion. Canadian cannabis companies, with their well-established infrastructure and international presence, are strategically positioned to capitalize on this growth. Tracking key stocks with solid fundamentals and technical setups becomes essential as investors look for potential gains.
Neutral
The Motley Fool
1 week ago
Better Marijuana Stock: Aurora Cannabis or Tilray Brands?
The global cannabis market tells a tale of survival and adaptation. After a brutal multiyear shakeout that saw dozens of companies fold or merge, the remaining players have emerged battle-tested and strategically transformed.
Neutral
PRNewsWire
1 week ago
Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect
NASDAQ | TSX: ACB The collaboration aims to broaden access of premium medical cannabis products to Australian patients EDMONTON, AB , Dec. 17, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce a distribution partnership between The Entourage Effect and MedReleaf Australia. The Entourage Effect provides comprehensive distribution and support services to pharmacies in Australia and will serve as a wholesaler for MedReleaf Australia's leading portfolio of products under the CraftPlant, Aurora, and IndiMed brands, furthering the mission to expand access for Australian patients.
Negative
Benzinga
1 month ago
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Cannabis stocks have faced significant challenges recently, driven by political uncertainty that has further weighed on a sector still struggling to regain its footing since the overhyped all-time highs of 2021.
Neutral
PRNewsWire
1 month ago
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB , Nov. 26, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces developments in cannabis science from Aurora's world class research and genetics facility, Aurora Coast. With a continued focus on premium, science-driven insights, these latest innovations demonstrate Aurora's commitment to providing patients with ongoing access to superior product offerings on AuroraMedical.com.
Negative
WSJ
1 month ago
Marijuana Industry Could Stay in Limbo Under Trump
A hands-off policy on cannabis will be a bad outcome for a business already struggling with ambiguous laws.
Neutral
PRNewsWire
1 month ago
Aurora Cannabis Expands Innovative Recreational Product Portfolio
NASDAQ | TSX: ACB Introduces New Products and Flavours across Greybeard, San Rafael '71 and Tasty's brands EDMONTON, AB , Nov. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is excited to announce its latest lineup of innovations from Greybeard, San Rafael '71 and Tasty's brands. With a continued focus on premium, science-driven offerings, this expanded lineup represents Aurora's commitment to delivering exceptional high quality, cutting-edge and diverse options for Canadian cannabis consumers.
Positive
Seeking Alpha
1 month ago
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pressures, but has significant upside potential with strategic buyers potentially paying mid- or high-teens per share. Casey's General Stores has outperformed its peers and the S&P 500 due to its strategic positioning in rural areas and strong operational execution.
Positive
MarijuanaStocks
1 month ago
3 Marijuana Stocks For Today Watchlist
The future of cannabis investing rests in the hands of politicians who may not have the industry's best interests at heart. Right now, the majority of marijuana stocks are feeling the impact of cannabis politics surrounding reform and regulatory issues. Each party, Republicans and Democrats, walks a different path to passing comprehensive reform and looking at the sector as a whole.
Charts implemented using Lightweight Charts™